Atea Pharmaceuticals, Inc. (AVIR) vs ARS Pharmaceuticals, Inc. (SPRY)
Atea Pharmaceuticals, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($414.7M and $412.7M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −184.3%) and the higher return on invested capital (0.00% vs −335.7%). Across the 16 metrics below, Atea Pharmaceuticals, Inc. leads on 13 and ARS Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | AVIR | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 71.37% | 65.16% |
| Operating margin | 0.00% | (184.96%) | 0.00% |
| Net margin | 0.00% | (184.26%) | 0.00% |
| Free cash flow margin | 0.00% | (167.97%) | 0.00% |
| Return on equity | (58.14%) | (210.37%) | (57.72%) |
| Return on assets | (52.99%) | (76.54%) | (49.22%) |
| Return on invested capital | 0.00% | (335.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack